Back to search

National and Kapodistrian University of Athens

Επιδημιολογική διερεύνηση πολυανθεκτικών μικροβιακών στελεχών που απομονώνονται σε ΜΕΘ

Abstract

dc:description

The aim of the study was to investigate the resistance mechanisms of multidrug- resistant K.pneumoniae isolates recovered from clinical samples of patients hospitalized in the ICU of the Serres General Hospital, during a 4 year period (2008-2011), as well as the effectiveness of the infection control intervention measures which were taken to restrain the dissemination of such pathogens.The selected isolates were tested by determination of agar dilution MICs, phenotypic carbapenemase testing, PCR testing, nucleotide sequencing and molecular typing (PFGE).During the study period, 49 imipenem- and/or meropenem-resistant K.pneumoniae isolates were recovered fron clinical samples of 36 distinct ICU patients. The most common type of sample from which these pathogens were isolated was urine (26.5%), followed by blood samples (20.4%), bronchial secretions (20.4%), and intravenous catheters (8.1%). Imipenem MICs ranged from 4 to > 32μg/ml while meropenem MICs ranged from 2 to > 32 μg/ml and all isolates were highly resistant to ertapenem with MICs of >32μg/ml. Furthermore, they were resistant to all b-lactams, including b-lactam – b lactamase inhibitor combinations and aztreonam, amikacin, trimethoprim- sulfamethoxazole, and ciprofloxacin. Antimicrobial alternatives to carbapenems that demonstrated in vitro activity included gentamicin, colistin, and tigecycline, with 43 (87.7%), 40 (83.6%) and 46 (94.5%) of the isolates being susceptible, respectively.Phenotypic and molecular testing showed that all 49 carbapenem – resistant isolates produced a KPC and/or an MBL-type carbapenemase. It should be noted that in all cases PCR testing confirmed the result of the phenotypic assays.One representative isolate per patient (a total of 36 isolates) was further tested. PCR and subsequent sequencing analyses revealed that 24 of the patients were infected with KPC-2 producers, 9 were infected with VIM – 1 producers, and 3 were infected with isolates producing both KPC-2 and VIM-1 enzymes. Phenotypic and molecular testing revealed the coproduction of an ESBL by 23 of the isolates harboring the gene for KPC, in 6 of those harboring the gene for VIM, and in 1 of those that produced both carbapenemases. Plasmidic genes for AmpC were not detected in any of the isolates.PFGE analysis of the representative isolates revealed that the K.pneumoniae isolates belonged to eight distinct PFGE clonal types (I-VIII), five of which contained two or three sybtypes.Almost half of the carbapenemase – producing clinical isolates (16; 44.4%) were identified during the second year of the study (2009) when no specific infection control measures had been undertaken. It should be noted that during the fourth quarter of 2009, as many as 10 cases were detected in the ICU. The number of clinical cases due to carbapenemase – producing K.pneumoniae decreased considerably during the next two years (2010; 11 cases, 30.5% - 2011; 5 cases, 13.8%) following the implementation of an intensified infection control intervention after 2009. The incidence of new cases per 1,000 patient days during the years 2009-2011 was 17.7, 11.9 and 5.4, respectively. After the implementation of the additional infection control measures in 2011, the number of new cases declined significantly from the first year of the study(p=0.0192).Environmental sampling detected only three carbapenem- resistant isolates during the ICU outbreak in the last quarter of 2009. Two isolates were recovered from ventilator samples, and one was from a bed sample. The KPC-2 enzyme was detected in two of these isolates, while the remaining one harbored both carbapenemases. PFGE analysis revealed that these environmental K.pneumoniae isolates were classified into clonal subtypes that were identified in the clinical isolates.During 2011, active surveillance of 97 (75.8%) of the 128 patients was performed within 24h after their admission to the ICU. As many as 11 (11.3%) of the patients screened were found to be colonized by carbapenem- resistant K.pneumoniae isolates. Molecular testing showed that all of the isolates produced the KPC-2 enzyme and eight also produced an ESBL ; they shared clonal subtypes which were identified among clinical isolates. In all cases, colonized patients were transferred to single ICU rooms and rigorous infection control measures were undertaken. Three of the 11 patients with positive cultures developed clinical infections due to KPC-2 producing K.pneumoniae within 4 to 16 days after their initial screening. Our findings suggest that rigorous infection control measures and active surveillance can effectively reduce the incidence of secondary transmission due to KPC – producing pathogens.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Chini, Maria
  • Χίνη, Μαρία

Subjects

dc:subject × 15

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/40757

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Chini, Maria; Χίνη, Μαρία. Επιδημιολογική διερεύνηση πολυανθεκτικών μικροβιακών στελεχών που απομονώνονται σε ΜΕΘ. National and Kapodistrian University of Athens, 2013. http://hdl.handle.net/10442/hedi/40757